Alegre, John Mark Y.

HRN: 28-69-98  Sex: Male

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
03/20/2026
METRONIDAZOLE 125MG/5ML, 60ML (BOT)
03/20/2026
03/27/2026
IV
5ml
TID
Intestinal Amoebasis
Checking Initial Appropriateness 

 Indication:  Empiric    Type of Infection:  Intra-abdominal    Compliance to guidelines: Compliant To Guidelines